Home  /  Resource Library  /  Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events

Article reviews diagnosis and management of side effects for Loncastuximab Tesirne for the treatment of DLBCL.